7.72
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Chromadex Corp Borsa (CDXC) Ultime notizie
ChromaDex Corp. Announces Name Change to Niagen Bioscience, Inc. and New Ticker Symbol "NAGE" Effective March 19, 2025 - BioSpace
ChromaDex to rebrand as Niagen Bioscience and change ticker - Investing.com India
Major Rebrand: ChromaDex Evolves to Niagen Bioscience, Sharpens Focus on Aging Science - StockTitan
ChromaDex to Present at the 37th Annual Roth Conference - Bluefield Daily Telegraph
Healthy Aging Leader ChromaDex Takes Center Stage at ROTH Conference Longevity Panel - StockTitan
ChromaDex (NASDAQ:CDXC) Given New $11.00 Price Target at HC Wainwright - Defense World
ChromaDex stock price target raised to $11 by H.C. Wainwright - Investing.com Australia
Chromadex corp. SVP buys $2,145 worth of common stock - Investing.com
ChromaDex Co. (NASDAQ:CDXC) Shares Bought by Rhumbline Advisers - Defense World
Truist Financial Corp Makes New $54,000 Investment in ChromaDex Co. (NASDAQ:CDXC) - Defense World
StockNews.com Downgrades ChromaDex (NASDAQ:CDXC) to Buy - Defense World
ChromaDex (NASDAQ:CDXC) Stock Price Expected to Rise, LADENBURG THALM/SH SH Analyst Says - Defense World
FY2025 EPS Estimates for ChromaDex Boosted by Roth Capital - Defense World
Earnings call transcript: Chromadex’s Q4 2024 earnings beat forecasts, stock rises - Investing.com Australia
ChromaDex Corporation Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next - Yahoo Finance
ChromaDex stock soars to 52-week high, touches $7.98 By Investing.com - Investing.com Canada
ChromaDex Reports Record Revenues Amid Challenges - TipRanks
Tru Niagen’s ChromaDex reports profit, nearly $100 million in yearly sales - SupplySide Supplement Journal
ChromaDex stock soars to 52-week high, touches $7.98 - Investing.com India
ChromaDex Corporation (NASDAQ:CDXC) Q4 2024 Earnings Call Transcript - Insider Monkey
ChromaDex: Q4 Earnings Snapshot - Midland Daily News
ChromaDex Corp (CDXC) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Advances - Yahoo Finance
ChromaDex shares rise as Q4 results top estimates - Investing.com India
ChromaDex Reports Strong 2024 Financial Performance - TipRanks
Earnings call transcript: Chromadex’s Q4 2024 earnings beat forecasts, stock rises By Investing.com - Investing.com South Africa
Chromadex Corp reports results for the quarter ended December 31Earnings Summary - TradingView
ChromaDex (CDXC) Q4 Earnings and Revenues Surpass Estimates - MSN
ChromaDex Corporation Reports Fourth Quarter and Fiscal Year 2024 Results - BioSpace
Chromadex Corp earnings beat by $0.07, revenue topped estimates - Investing.com South Africa
CHROMADEX Earnings Results: $CDXC Reports Quarterly Earnings - Nasdaq
ChromaDex shares rise as Q4 results top estimates By Investing.com - Investing.com South Africa
ChromaDex Corporation Reports Fourth Quarter and Fiscal Year 2024 Results -March 04, 2025 at 04:56 pm EST - Marketscreener.com
Chromadex Reports Strong Q4 2024 Financial Growth - TipRanks
ChromaDex: Q4 Earnings Snapshot -March 04, 2025 at 04:17 pm EST - Marketscreener.com
ChromaDex sees FY25 revenue growth roughly 18% - TipRanks
ChromaDex sees FY25 revenue up 18% - TipRanks
What To Expect From ChromaDex Corp (CDXC) Q4 2024 Earnings - GuruFocus.com
CHROMADEX Earnings Preview: Recent $CDXC Insider Trading, Hedge Fund Activity, and More - Nasdaq
ChromaDex (CDXC) Expected to Announce Earnings on Tuesday - Defense World
ChromaDex (NASDAQ:CDXC) Rating Increased to Strong-Buy at StockNews.com - MarketBeat
Dartmouth Wants Fed. Circ. To Ax Fees After Vitamin IP Loss - Law360
Chromadex Corp expected to post earnings of 2 cents a shareEarnings Preview - TradingView
ChromaDex analysis of NR products yields ‘disappointing’ results - NutraIngredients-usa.com
Investor Network: ChromaDex Corporation to Host Earnings Call - ACCESS Newswire
ChromaDex Corporation to Host Earnings Call - ACCESS Newswire
Chromadex Corp. to Host Earnings Call - ACCESS Newswire
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):